Guardant Health
GH
#1003
Rank
HK$187.21 B
Marketcap
HK$1,395
Share price
1.75%
Change (1 day)
185.32%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -HK$27.26

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -HK$27.38. In 2025 the company made an earnings per share (EPS) of -HK$25.97 an increase over its 2024 EPS that were of -HK$27.93.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$27.264.96%
2025-HK$25.97-7.02%
2024-HK$27.93-16.82%
2023-HK$33.58-33.12%
2022-HK$50.2260%
2021-HK$31.3955.04%
2020-HK$20.24207.14%
2019-HK$6.59-19.81%
2018-HK$8.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-HK$0.28-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$19.22-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA